Search
  • 网站搜寻
亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。
返回搜索结果

Constrained proteins and uses therefor (PH tag)


总结

MicroCubes are protein-based vaccines that can accommodate various antigens and elicit strong T-cell responses. They distinguish themselves by unique crystalline organisation, resulting in slow-release of the antigen and self-adjuvanted stimulation of both arms of the immune system.


技术优势

- Versatile vaccine platform to deliver a wide range of antigens.
- Induce strong antigen-specific cellular and humoral immune responses without additional adjuvant
- Heat, freeze, and protease-resistance facilitates vaccine storage
- Second generation ‘PH-MicroCube’ can accommodate full-length, functional membrane proteins with native structure


技术应用

Vaccine platform


详细技术说明

The ease of design and versatility of MicroCubes supports their use as a potential generic platform for vaccines against cancer and infectious diseases such as HIV, Hep B, influenza and TB. The superior stability of MicroCubes indicates that they will be particularly suitable in cases where the cold chain is too costly or is impractical to maintain. They have been developed from protein crystals produced by common insect viruses. These crystals function to protect the virus particles and are thus robust and able to package large protein cargoes.

We have engineered MicroCubes to incorporate antigens of interest in place of the virus particles, thereby exploiting their remarkable robustness and multivalent presentation of antigens. Importantly, their capacity to accommodate cargoes of different sizes and structures is unique, and vastly superior to that of traditional virus-like particles. Murine immunisation studies showed no toxic effect of MicroCubes and demonstrated that HIV Gag MicroCubes induce robust Gag-specific humoral and cellular responses. The technology has also demonstrated promising results when applied to the HA hemagglutinin antigen in a murine challenge model of influenza.


合作类型

Licensing


申请日期

21/07/2015 00:00:00


申请号码

AU2015292261
Others


其他

Monash seeks a partner to optimise and adapt the MicroCube system for application.


ID号码

2014-029


国家/地区

澳洲

欲了解更多信息,请点击 这里
Business of IP Asia Forum
桌面版